Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03834350 · ClinicalTrials.gov registry record · NA

At Home Spirometry and Video Module Education for COPD Patients

A NA study of COPD, sponsored by University of Chicago.

Completed
Registry status
NA
Development phase
71
Enrollment target
1
Study location

NCT03834350 is a NA study of COPD that has completed, run by University of Chicago. The registered enrollment target is 71 participants, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03834350, a NA study of COPD, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
NA
Development phase
71 participants
Enrollment target
1
Study location

Study Summary

The central hypothesis is that patients hospitalized for COPD who subsequently complete the at-home BREATHES Program with V-TTG skill training and SpiroPD adherence support will retain increased medication knowledge, skill, self-efficacy, and adherence that otherwise decays substantially by 30 days post-discharge. To test this hypothesis, this study proposes the following specific aims: Aim 1: Determine the feasibility of, adherence to, and efficacy of at-home V-TTG for ongoing inhaler skill training. Hypothesis: Participants who complete both in-hospital and at-home V-TTG will have a significantly increased likelihood of demonstrating effective respiratory inhaler technique within 30 days after hospital discharge compared to in-hospital technique Aim 2. Determine the feasibility of, adherence to, and efficacy of at-home SpiroPD for COPD medication adherence support. Hypothesis: Participants' use of SpiroPD (PMD Healthcare) will significantly improve their COPD medication adherence.

Conditions Studied

Interventions

  • OTHER BREATHES Program
  • DEVICE BREATHES SpiroPD or Propeller Health

Study Locations (1)

Illinois

  • University of Chicago Medicine - Chicago

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2019-04-11
Est. Completion 2021-06-23
Phase NA

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT03834350

The ClinicalTrials.gov registry entry for NCT03834350 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (97% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COPD appearing as the primary indexed condition, and to 2 interventions - of which BREATHES Program is the first listed.

NCT03834350 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT03834350 about?

NCT03834350 is a clinical study titled "At Home Spirometry and Video Module Education for COPD Patients". The central hypothesis is that patients hospitalized for COPD who subsequently complete the at-home BREATHES Program with V-TTG skill training and SpiroPD adherence support will retain increased medication knowledge, skill, self-efficacy, and adherence that otherwise decays substantially by 30 days ...

What is the current status of trial NCT03834350?

This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2019-04-11. Estimated completion is 2021-06-23.

What conditions does trial NCT03834350 study?

This clinical trial studies the following conditions: COPD.

What interventions are being tested in trial NCT03834350?

The interventions under investigation include: BREATHES Program (OTHER), BREATHES SpiroPD or Propeller Health (DEVICE).

Who is sponsoring clinical trial NCT03834350?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03834350 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COPD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.